// App-Quantinova.ai

638 : Biomarq: A novel approach to automated HER2-analysis of circulating tumor cells (CTCs).

Researchers

Presenter

  • Aurelia Pestka

Principal Investigators

  • Thomas W. P. Friedl

  • Leonie Majunke

  • Wolfgang Janni

  • Julia Katharina Neugebauer

  • Julia Kathrin Jueckstock

  • Jan Keij

  • Klaus Friese

  • Tanja N. Fehm

  • Volkmar Mueller

Medical Centers

  • Veridex LLC, Huntingdon Valley, PA

  • Department of Gynecology, University Medical Center Hamburg-Eppendorf, Hamburg, GermanyDepartment of Gynecology and Obstetrics. Klinikum der Ludwig-Maximilians-Universitaet Muenchen, Munich, GermanyDepartment of Gynecology and Obstetrics, Klinikum der Ludwig-Maximilians-Universitaet, Munich, Germany

  • Department of Gynecology and Obstetrics University Ulm, Ulm, Germany

  • Department of Gynaecology and Obstetrics, University Hospital of Ludwig-Maximilians-University Munich, Munich, Germany

  • Department of Gynecology and Obstetrics Ludwig-MaximiliansUniversity, Munich, Germany

  • Department of Gynecology and Obstetrics, University of Tuebingen, Tuebingen, Germany

  • Department of Gynecology and Obstetrics Ludwig-MaximiliansUniversity, Munich, Germany

  • Universitatsklinikum Ulm, Ulm, Germany

Locations

  • United States

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

Biomarkers

  • Circulating tumor cells

  • Human epidermal growth factor receptor 2

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved